Cabinet Kohen Avocats · Paris 16ᵉ
Can an American Contest a French Will When the Testator Had Dementia? Medical Evidence, Capacity, and Procedure

Maître Hassan KOHEN intervient en urgence, du commissariat à la cour d'assises. Première analyse stratégique : 80 € TTC, réponse personnelle sous 24 heures.

100 % confidentiel · Secret professionnel · Sans engagement

Article généré par une intelligence artificielle, selon un processus conçu et contrôlé par le cabinet

Source : Cour de cassation – Base Open Data « Judilibre » & « Légifrance ».

Barreau de Paris Garde à vue, instruction, assises Fiche CNB avocat.fr
Maître Hassan KOHEN, avocat au Barreau de Paris
Maître Hassan KOHEN
Avocat au Barreau de Paris

Can an American Contest a French Will When the Testator Had Dementia? Medical Evidence, Capacity, and Procedure

Parler à un avocat 06 89 11 34 45

An American heir may be able to challenge a French will signed when a parent or other relative had dementia, Alzheimer’s disease, or serious cognitive decline. The diagnosis alone, however, does not decide the case. French courts focus on whether the person had a mental disorder that prevented a sufficiently informed and voluntary testamentary decision at the precise time the will was made. A clear will signed during a lucid period may survive a challenge; a handwritten or notarized document may be annulled when medical records, witness evidence, and the surrounding chronology show that the testator could not understand the act.

This subject uses French legal terms that can be unfamiliar to an American reader. A testament is a will, a testateur is the person who makes it, a notaire is a French civil-law notary, and an assignation is the formal summons that starts civil litigation. The core claim is usually a request for nullité, meaning that the court should treat the will as legally ineffective. The relevant evidence, limitation period, court procedure, and rules on medical confidentiality must be analyzed together.

The cross-border element matters. The deceased may have lived in France, held American citizenship, owned property in several states, or signed earlier U.S. documents. This guide explains how to separate governing law from medical capacity, how to build proof from the United States, and how to act quickly while a French notary is administering the estate. It complements the firm’s general guide to challenging a French will by concentrating on the narrower and more evidence-intensive dementia question.

I. Can an American Contest a French Will Signed During Dementia?

A. What French law means by testamentary capacity, and why the signing date controls

The first question is not whether the claimant is American. It is which law governs the succession and the particular issue being raised. Regulation (EU) No 650/2012 is the principal European instrument used by French courts for many international succession questions. The official English text of Regulation 650/2012 generally connects the succession to the deceased person’s habitual residence at death and permits a person, subject to its conditions, to choose the law of the state of their nationality for the succession. The United States is not a participating European Member State, but a U.S. citizen’s nationality, French residence, choice-of-law clause, and the location of assets may still be relevant to the French conflict-of-laws analysis.

Do not confuse succession law with the law of the asset or with tax law. A French apartment, a U.S. brokerage account, and a life-insurance policy may raise different connecting factors. The France–United States estate and gift tax convention deals with taxing rights and relief from double taxation; it does not decide whether a person understood a will. The 1978 convention published on Légifrance and the 2004 amendment published on Légifrance should therefore be reviewed for financial consequences only after the civil validity question has been framed.

For an American family, the first working document should be a governing-law map. Put the following information in separate columns:

  • the deceased person’s habitual residence and domicile at death;
  • every nationality held by the deceased and any express choice-of-law clause;
  • the place and form of each will, codicil, trust document, or beneficiary designation;
  • the location and legal nature of the significant assets; and
  • the family relationships that may create a protected inheritance share under French law or another law.

This map prevents a common mistake: assuming that the law of the state where an American heir lives determines whether a French parent was capable of signing a French testament. It may not. The law governing the succession can differ from the procedural law of the court, and both can differ from the law governing a U.S. bank account. A French lawyer should identify the governing law before the family spends money on a medical expert whose opinion is directed at the wrong legal test.

The second question is what kind of challenge is actually being considered. A dementia-based challenge is normally a capacity or consent claim. It argues that the testament was made when the testator could not form a legally effective intention. A formal challenge alleges that an olographic will was not handwritten, dated, or signed as French law requires, or that a public will did not follow the required notarial process. A forgery claim attacks authorship or alteration. A fraud, pressure, or violence claim attacks the circumstances in which the testament was obtained. A reduction claim is different: it accepts that the will may be valid but argues that its gifts exceed the portion that the deceased could freely leave.

French law calls the protected portion the réserve héréditaire, or reserved share, and the freely disposable portion the quotité disponible. Article 912 of the Civil Code defines those concepts. Article 913 sets the ordinary limits when the deceased leaves children. If the will is valid but leaves an American child less than the applicable protected share, the appropriate remedy may be reduction rather than annulment for dementia. The evidence then shifts from medical capacity to family status, lifetime gifts, asset values, and the calculation of the estate.

The legal capacity standard appears in Article 414-1 of the Civil Code. It states: Pour faire un acte valable, il faut être sain d’esprit. C’est à ceux qui agissent en nullité pour cette cause de prouver l’existence d’un trouble mental au moment de l’acte. In English, the person who seeks nullity generally has to prove a mental disorder at the time of the act. A will is a gratuitous transfer, or libéralité. Article 901 applies the same central protection to a gratuitous disposition: Pour faire une libéralité, il faut être sain d’esprit. The same article also addresses consent affected by mistake, fraud, or violence.

“Dementia” is therefore a medical description, not an automatic legal conclusion. A person may have a diagnosed neurocognitive disorder and still understand a particular transaction on a particular day. Another person may have no final diagnosis but display confusion, delusions, severe aphasia, or an inability to understand property and family relationships when signing. The court asks what the evidence shows about the testamentary act, not simply what label appears in the medical file.

The date-specific requirement is especially important where dementia progressed gradually or included lucid intervals. Evidence that a parent was independent two years before the will may not answer the question. Evidence that the parent was hospitalized two weeks after signing may be powerful but still needs a medical and factual connection to the signing date. The closer the evidence is to the act, the easier it is to explain the progression; the further away it is, the more carefully the expert and the judge must reconstruct the intervening period.

Recent French decisions illustrate both sides of the analysis. In Cass. 1re civ., May 20, 2026, no. 24-13.903, the Cour de cassation addressed a testament and related beneficiary changes in the context of a mental disorder. Its reasoning states: la conscience de la portée d’un acte qu’en a son auteur n’exclut pas que celui-ci l’ait fait sous l’empire d’un trouble mental. The English lesson is precise: knowing what an act says or what result it is intended to produce does not, by itself, rule out a legally relevant mental disorder. The court must still connect the disorder to the act and the evidence in the case.

In Cass. 1re civ., March 6, 2013, no. 12-17.360, published in the Bulletin, the Court examined a challenge to multiple testaments and required the lower court’s reasoning to be tied to the relevant dates rather than broad, generalized observations. This is a critical protection for both sides. An heir cannot win simply by showing that the testator eventually developed dementia, and a beneficiary cannot win simply by pointing to the existence of a signature or a notary’s reassuring formula.

A French court can also consider the difference between a mental disorder and a defect in free consent. A beneficiary who isolates an elderly person, controls appointments, withholds family communications, threatens loss of care, or arranges a sudden testamentary change may create evidence relevant to fraud, pressure, or violence. Those facts do not automatically prove undue influence, a term commonly used in American practice. French counsel must select the legal ground that matches the evidence, because the elements, burden, and remedy may differ from the law of an American state.

Standing is another early issue. The person who objects must have a legally protected interest, not merely a sense that the result is unfair. A child, surviving spouse, heir under intestacy, or universal successor may have a different position from a person who would only have received a specific gift under an earlier document. Decision 2012-288 QPC of the Constitutional Council reproduces the limits in Article 414-2 concerning post-death challenges to acts other than lifetime gifts and testaments. In Cass. 3e civ., October 12, 2022, no. 21-15.669, the Court quoted the rule that heirs may challenge an act autre qu’une donation entre vifs et un testament in the specified circumstances. That wording matters: the special limitation in Article 414-2 must not be mechanically applied to a testament, but the claimant still needs a real legal interest and a coherent cause of action.

Older estates require a version check. In Cass. 1re civ., June 12, 2013, no. 12-15.688, the Court explained that the rules introduced by the 2007 reform of protection for adults did not automatically apply retroactively to acts completed before January 1, 2009. If the disputed testament or related act is old, counsel should identify the text in force on the signing date before relying on a current provision or a modern protection measure.

B. Which defects can invalidate the document, and what a notary’s role does not prove

Capacity and form are separate questions. A handwritten will is a testament olographe. Article 970 of the Civil Code provides: Le testament olographe ne sera point valable s’il n’est écrit en entier, daté et signé de la main du testateur : il n’est assujetti à aucune autre forme. The English meaning is that the will must be entirely handwritten, dated, and signed by the testator. A typed document bearing a handwritten signature raises a formal problem; it is not converted into a valid French olographic will merely because the signature looks genuine.

A public or notarial will is a testament authentique. Article 971 states that it is received by two notaries or by one notary assisted by two witnesses. Article 972 addresses dictation, reading, signatures, and the use of an interpreter where the testator does not speak French. A French notary’s presence is important evidence of the formal process, but it is not an absolute medical certification. The notary may observe a person for a limited appointment; the court can later consider medical records, witnesses, communications, and the person’s behavior over the surrounding period.

A notarial will is also not immune from a capacity challenge. In the Court of Appeal of Montpellier, July 4, 2025, RG no. 22/03181, the court applied Articles 901 and 414-1 to a testamentary dispute and examined medical evidence in relation to the act, rather than treating the appointment of a protective representative or the visual regularity of the document as conclusive. The result of any case depends on its evidence, but the principle is useful for an American family: “notarized” describes the form; it does not answer every capacity question.

The reverse is also true. A handwritten will is not automatically invalid because the writer had dementia, was elderly, or made an unexpected gift. In the Court of Appeal of Agen, June 3, 2026, RG no. 25/00559, the court reviewed medical records, witness statements, and the observations recorded by two notaries before concluding that the claimant had not proved the father’s incapacity on the signing date. The decision repeats the practical rule that Celui qui agit en nullité de la libéralité pour insanité d’esprit doit prouver l’existence d’un trouble mental au moment de l’acte. The case is a reminder to test the evidence rather than rely on the diagnosis alone.

A document may also be invalid for a reason that has nothing to do with dementia. The original may contain a missing date, a signature placed before the testamentary text, a page added later, handwriting that is not the testator’s, or an unexplained change from an earlier will. A court may need an expert in handwriting, document examination, or psychiatry. These questions should be pleaded in an organized way. A capacity expert should not be asked to decide whether a beneficiary was morally deserving, and a handwriting expert should not be asked to decide whether the testator understood a tax consequence.

French law also distinguishes the existence of a will from the steps used to bring it into the succession file. Article 1007 of the Civil Code concerns the opening and description of certain wills deposited with a notary. It does not replace a full action seeking nullity for incapacity, fraud, violence, or forgery. Ask for the original document, the notarial record of deposit or opening, the identity of the person who delivered it, the date of delivery, and the existence of any previous testament or revocation.

If the court annuls the disputed will, the result is not necessarily that the American claimant receives every asset. The court must identify the legal consequence: an earlier valid will may revive, intestacy rules may apply, a later clause may remain effective, or the estate may still need a separate calculation of reserved shares. This is why an American heir should plead the primary capacity claim and, where supported by the evidence, a properly framed alternative claim about form, revocation, fraud, or the reserved share.

The cross-border tax result remains separate. A beneficiary who receives property after a civil judgment may need to correct French inheritance-tax filings and U.S. estate or income-tax reporting. The treaty may reduce double taxation, but it cannot cure a legally ineffective testament. The civil case should therefore identify the tax consequences without allowing tax terminology to obscure the question the judge must decide: whether the will legally expressed the testator’s will.

II. What Evidence, Deadline, and French Procedure Apply to a Dementia-Based Challenge?

A. How should an American heir preserve medical proof and obtain the original will?

The strongest case file is chronological. Put the will’s date and, if known, its time and location at the center of a timeline. Add medical appointments, emergency visits, hospital admissions, medication changes, cognitive assessments, home-care reports, financial transactions, protection proceedings, notarial appointments, and communications with relatives. The objective is not to collect every unpleasant memory. It is to show what the testator could understand, explain, and decide around the act in dispute.

Start with the original will. A photograph, scan, or transcription sent by a relative may conceal the features that matter: ink changes, folds, staple holes, additions, handwriting pressure, a missing page, an unusual date, or the position of the signature. Request the original from the notary or the person holding it through counsel. Preserve the digital copy exactly as received, including its file name, email headers, and metadata. Do not annotate the only copy. If the original is said to be unavailable, record who said so, when, and what searches have been made.

Then identify every earlier and later testament. The official Service-Public explanation of the FCDDV describes the fichier central des dispositions de dernières volontés, or central file of last wills. It records the existence and location of wills entrusted to notaries, not the testamentary contents themselves. Any person can request an interrogation after death with the required death certificate, while the notary administering the succession may make the request. The FCDDV is a starting point for locating documents, not proof that the latest will is valid.

For medical proof, request records that cover the signing date rather than a generic diagnosis. Useful records may include a general practitioner’s notes, neurologist or geriatrician assessments, emergency records, medication lists, cognitive testing, nursing or home-care reports, communications about an inability to manage finances, and documentation of a guardianship or curatorship application. A French curatelle is a court-supervised assistance measure for an adult who needs help with important acts; a tutelle is a more extensive representation measure. Either may be relevant context, but neither alone proves that the person lacked testamentary capacity on a particular date.

Ask each witness a narrow factual question. Did the testator recognize the people in the room? Could the testator explain the property being given? Did the testator understand who would receive it and who would be excluded? Did the testator initiate the appointment or merely repeat words supplied by someone else? Was there a conversation about prior wills? Did the testator display delusions, disorientation, or an inability to manage a simple decision? A witness who gives a date, setting, and observable behavior is usually more useful than a witness who only says that the person “had dementia for years.”

Medical evidence can be retrospective, but it must be reasoned. A doctor who treated the person shortly before the will may be able to explain the significance of contemporaneous observations. A court-appointed expert may review records and interview witnesses to assess the testator’s mental state at the relevant time. The expert should distinguish a diagnosis, a loss of autonomy, a medication side effect, a temporary delirium, and the legally relevant inability to form an informed testamentary intention. The opinion must explain the bridge between the clinical evidence and the exact act.

A decision of the Paris Court of Appeal shows how this pre-trial work can be structured. In September 15, 2023, RG no. 23/01341, the court ordered an expert assessment and gave the expert a mission that included determining si au moment où a été établi le testament, [A] [Z] avait un discernement ou une volonté suffisante pour rédiger un testament. The order also allowed review of medical records and relevant banking material. For an American heir, the practical lesson is that a request for an expert should identify the precise date, the precise testament, and the records needed to answer the legal question.

Before a full lawsuit, Article 145 of the Code of Civil Procedure allows a person with a legitimate reason to seek a legally admissible investigative measure to preserve or establish evidence before trial, by application or in summary proceedings. This can matter when a medical practice holds records, a bank holds statements, a notary has the original, or a neutral expert is needed before the evidence disappears. The measure is not a guaranteed preview of the merits. It is a tool for securing evidence when a real future dispute is possible and the request is proportionate.

The American Court of Appeal decision just described is useful because it did not treat the preliminary expert application as a final ruling that the will was invalid. It examined whether a future action was possible and whether the requested medical and financial material could improve the claimant’s evidence. A French lawyer can evaluate whether Article 145, a request to the notary, a court order for production, or another procedure is appropriate. Do not assume that an American subpoena or a HIPAA authorization will automatically compel a French doctor to send a complete file to a U.S. relative.

Records originating in the United States should be preserved in their native form. Keep the original electronic export of texts and emails, the audit history where available, the provider’s identifying information, and a translation that can be checked against the original. Birth, marriage, adoption, and death certificates may need certified copies, an apostille, and a certified French translation, depending on the receiving authority. A French court can evaluate foreign evidence, but a document that cannot be authenticated or translated may delay the case or reduce its practical value.

Medical privacy requires care. The American heir should not circulate a parent’s full medical file to every family member or attach sensitive records to an unprotected email. Counsel can determine which records are relevant, who may request them, and whether a court order or expert process is needed. The request should be limited to the records that can illuminate capacity, consent, or the surrounding circumstances. A broad fishing request can create privacy objections and distract from the date-specific proof required by Articles 414-1 and 901.

For an influence or pressure theory, add the non-medical chronology. Preserve caregiver schedules, appointment records, call logs, text messages, emails, powers of attorney, unusual transfers, changes to bank beneficiaries, transportation records, and evidence of who controlled access to the testator. Keep original screenshots and exports rather than only copied images. Note when a beneficiary first learned about an intended gift, who arranged the notarial meeting, and whether the testator had an independent opportunity to speak with the notary or a doctor.

For handwriting or alteration, gather comparison specimens from the same period: signed checks, letters, passports, forms, greeting cards, and bank documents. Do not write on them, crop away their provenance, or mix photocopies with originals without labeling the source. The document expert may need the original paper and ink. A private opinion based on a compressed phone image may help counsel formulate a request, but it may not be a substitute for a court-supervised examination.

Finally, keep the civil-status file separate from the medical file. The claimant must prove both legal interest and the factual ground for nullity. Certified records may show that the claimant is a child or spouse, while the medical and witness evidence addresses capacity. If the will is valid but the family relationship creates a reserved share, the asset and gift inventory becomes central instead. A coherent file lets the court understand the relief requested without forcing every issue into the dementia allegation.

B. What deadline and French procedure should an American heir follow?

Time begins to matter as soon as the death and the disputed will become known. Record the date of death, the date the notary opened or deposited the will, the date you first received a copy, the date a beneficiary claimed the assets, and the date of every written objection. Do not wait for a family meeting to decide whether the will is “really unfair.” A limitation defense may be raised while the medical file is still incomplete.

For a dementia-based nullity action by an heir, French case law has treated the action as subject to a five-year limitation period and has tied the starting point to the opening of the succession rather than to the earlier signing date. In Cass. 1re civ., March 20, 2013, no. 11-28.318, the Court’s published summary states that la prescription ne peut commencer à courir avant le décès du testateur. The rule is highly practical: an heir does not normally have a post-death testament challenge before the testator has died and the succession has opened.

The exact limitation analysis still depends on the claim, the statutory version, and the procedural history. Article 2224 of the Civil Code states the general five-year rule for personal or movable actions from the day the right-holder knew or should have known the facts allowing the action. Older decisions may refer to Article 1304, and exceptional legislation may have affected a particular period. In Cass. 1re civ., November 19, 2025, no. 23-19.695, the Court analyzed the five-year period applicable to an older testamentary dispute and the effect of the 2020 emergency-period legislation. The safe practice is to have French counsel calculate the deadline from the death, the applicable statute, and every possible interruption or suspension.

Do not use the deadline for a reserved-share claim as if it were the deadline for incapacity. Article 921 of the Civil Code provides a special rule for an action to reduce gifts that infringe a reserved share: five years from the opening of the succession, or two years from knowledge of the infringement, with an outer limit of ten years from death. That claim assumes that the disposition is legally effective but exceeds the disposable portion. It does not replace the capacity analysis for a will signed by a person with dementia.

If the notary is preparing to deliver or distribute assets, send a prompt written notice identifying the disputed will, the legal grounds under review, the requested preservation of the original, and the risk of irreversible transfer. A notary administers the succession and can communicate with the parties, but is not the judge who finally decides every claim of incapacity, fraud, or forgery. A notice to the notary is not automatically an injunction and may not interrupt a limitation period. It should be coordinated with the procedural step selected by French counsel.

The merits action is normally started by an assignation, a formal summons served on the defendants and filed with the competent tribunal judiciaire, the ordinary civil trial court. The competent venue may depend on the deceased’s last residence, the location of French real estate, the nature of the action, and international jurisdiction rules. All persons whose rights may be affected may need to be joined. A U.S. attorney’s demand letter does not itself start a French civil action, and a U.S. probate filing does not automatically determine the validity of a testament affecting a French succession.

An American heir can usually participate from the United States through a French lawyer, a carefully drafted power of attorney, document exchange, and remote preparation for hearings where permitted. Service on a beneficiary in the United States must follow the applicable international service rules. Translation, notarization, apostille, and representation costs should be estimated at the beginning. A power of attorney should say whether the representative may obtain records, instruct experts, accept service, negotiate a settlement, or make a binding renunciation. General language may not safely cover each of those acts.

Interim protection may be needed when there is a risk that a French property will be sold or estate funds will be released. The remedy must be tailored to the asset and the urgency. A court may order preservation, document production, or an expert measure; it does not automatically freeze every estate simply because a will is disputed. Where several heirs hold property together, Article 815 of the Civil Code states that no person can be forced to remain in indivision, meaning shared ownership, and that partition can generally be sought. That rule is not a substitute for a protective order, but it explains why delay can create a practical risk for an American claimant who is abroad.

While the civil action proceeds, the family should track tax filings separately. French inheritance-tax deadlines can apply even when the beneficiary identity is contested. The French tax administration publishes guidance for non-resident successions, including the office responsible for filing and payment, on its official non-resident inheritance-tax page. The estate and gift tax treaty can affect the allocation of taxing rights and credits, but it does not extend a civil limitation period or establish testamentary capacity. If the beneficiary changes after judgment, the parties should ask tax counsel whether an amended or protective filing is needed.

A practical action sequence for an American heir is:

  1. Write down the death date, the first-discovery date, the will date, and every notice received from the notary or beneficiary.
  2. Obtain the original will, the notarial deposit or opening record, the FCDDV information, and every earlier or later testament.
  3. Classify the claim as capacity, form, forgery, fraud or violence, revocation, standing, or reserved-share reduction.
  4. Build a date-specific medical and witness chronology covering the months before and after the signing.
  5. Preserve U.S. records in their original form and arrange authentication and certified French translation where required.
  6. Ask French counsel to calculate the limitation period and choose between a direct action, an Article 145 evidence measure, an urgent application, or several coordinated steps.
  7. Notify the notary and relevant beneficiaries in a way that preserves the objection without assuming that correspondence stops the clock.
  8. Coordinate the civil case with French inheritance-tax and U.S. estate-tax reporting, without treating tax filings as proof that the will is valid.

The evidence should then be tested against the legal question. If the records show a stable period of understanding at the signing date, the capacity claim may be weak even though dementia was diagnosed. If the records show severe confusion, an inability to manage basic affairs, a sudden unexplained beneficiary change, and a medical decline immediately around the will, the case may justify an expert assessment and a full nullity action. The judge will weigh the complete record, not one document in isolation.

Conclusion

An American can potentially contest a French will signed by a person with dementia, but the case turns on proof of the testator’s mental state at the time of the testamentary act. A diagnosis, advanced age, a protective measure, or an unexpected result may provide context; none automatically proves nullity. The decisive file connects contemporaneous medical evidence, neutral witness observations, the original document, the notarial process, and the testator’s ability to understand the people and property affected.

The first priorities are to identify the governing law, preserve the original will, locate earlier and later testamentary documents, record the death and discovery dates, and secure relevant medical and electronic evidence. French counsel can then separate a capacity claim from a formal defect, fraud or violence, revocation, or reserved-share action; calculate the correct deadline; and determine whether an Article 145 evidence application or an urgent protective measure is justified.

For an heir living in the United States, distance does not remove the right to act, but it makes early coordination more important. Certified civil-status records, reliable translations, authenticated U.S. evidence, a precise power of attorney, and a clear French litigation plan can prevent a promising challenge from being lost to delay or procedural confusion. The France–U.S. tax treaty may address the financial consequences, but only the civil analysis can determine whether the disputed will should govern the French succession.

📄 Circulaire officielle